Aquaporin-4 in brain and spinal cord oedema

Neuroscience

Volumn 168, Issue 4, 2010, Pages 1036-1046

  Saadoun, S ^a   Papadopoulos, M C ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

AQP4; Astrocyte; Brain; Devic's; Spinal cord; Water channel

Indexed keywords

AQUAPORIN; AQUAPORIN 4; AQUAPORIN 4 ACTIVATOR; AQUAPORIN 4 INHIBITOR; AUTOANTIBODY; CENTRAL NERVOUS SYSTEM AGENTS; CORTICOSTEROID; DEXAMETHASONE; IMMUNOGLOBULIN G ANTIBODY; MANNITOL; METHYLPREDNISOLONE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

AUTOREGULATION; BLOOD BRAIN BARRIER; BRAIN ABSCESS; BRAIN EDEMA; BRAIN HERNIA; BRAIN ISCHEMIA; BRAIN TUMOR; CELL SWELLING; CEREBROSPINAL FLUID FLOW; CLINICAL TRIAL; DECOMPRESSIVE CRANIECTOMY; DEMYELINATING DISEASE; DISEASE COURSE; DRUG SYNTHESIS; HUMAN; HYPONATREMIA; INTRACRANIAL HYPERTENSION; MENINGITIS; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SPINAL CORD COMPRESSION; SPINAL CORD DECOMPRESSION; SPINAL CORD DISEASE; SPINAL CORD EDEMA; SPINAL CORD INJURY; WATER TRANSPORT; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOLOGICAL MODEL; EDEMA; METABOLISM; SPINAL CORD DISEASES;

ANIMALS; AQUAPORIN 4; BRAIN EDEMA; EDEMA; HUMANS; MODELS, NEUROLOGICAL; SPINAL CORD DISEASES;

EID: 77953686706     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.08.019     Document Type: Review

References (89)

1. Amiry-Moghaddam M., Frydenlund D.S., Ottersen O.P. Anchoring of aquaporin-4 in brain: molecular mechanisms and implications for the physiology and pathophysiology of water transport. Neuroscience 2004, 129:999-1010.
2. Amiry-Moghaddam M., Otsuka T., Hurn P.D., Traystman R.J., Haug F.M., Froehner S.C., Adams M.E., Neely J.D., Agre P., Ottersen O.P., Bhardwaj A. An alpha-syntrophin-dependent pool of AQP4 in astroglial end-feet confers bidirectional water flow between blood and brain. Proc Natl Acad Sci U S A 2003, 100:2106-2111.
3. Amiry-Moghaddam M., Williamson A., Palomba M., Eid T., de Lanerolle N.C., Nagelhus E.A., Adams M.E., Froehner S.C., Agre P., Ottersen O.P. Delayed K+ clearance associated with aquaporin-4 mislocalization: phenotypic defects in brains of alpha-syntrophin-null mice. Proc Natl Acad Sci U S A 2003, 100:13615-13620.
4. Amiry-Moghaddam M., Xue R., Haug F.M., Neely J.D., Bhardwaj A., Agre P., Adams M.E., Froehner S.C., Mori S., Ottersen O.P. Alpha-syntrophin deletion removes the perivascular but not endothelial pool of aquaporin-4 at the blood-brain barrier and delays the development of brain edema in an experimental model of acute hyponatremia. FASEB J 2004, 18:542-544.
5. Araque A. Astrocyte-neuron signaling in the brain-implications for disease. Curr Opin Investig Drugs 2006, 7:619-624.
6. Auguste K.I., Jin S., Uchida K., Yan D., Manley G.T., Papadopoulos M.C., Verkman A.S. Greatly impaired migration of implanted aquaporin-4-deficient astroglial cells in mouse brain toward a site of injury. FASEB J 2007, 21:108-116.
7. Badaut J., Brunet J.F., Grollimund L., Hamou M.F., Magistretti P.J., Villemure J.G., Regli L. Aquaporin 1 and aquaporin 4 expression in human brain after subarachnoid hemorrhage and in peritumoral tissue. Acta Neurochir Suppl 2003, 86:495-498.
8. Badaut J., Brunet J.F., Petit J.M., Guerin C.F., Magistretti P.J., Regli L. Induction of brain aquaporin 9 (AQP9) in catecholaminergic neurons in diabetic rats. Brain Res 2008, 1188:17-24.
9. Badaut J., Regli L. Distribution and possible roles of aquaporin 9 in the brain. Neuroscience 2004, 129:971-981.
10. Bagnall A.M., Jones L., Duffy S., Riemsma R.P. Spinal fixation surgery for acute traumatic spinal cord injury. Cochrane Database Syst Rev 2008, CD004725.
11. Bloch O., Auguste K.I., Manley G.T., Verkman A.S. Accelerated progression of kaolin-induced hydrocephalus in aquaporin-4-deficient mice. J Cereb Blood Flow Metab 2006, 26:1527-1537.
12. Bloch O., Papadopoulos M.C., Manley G.T., Verkman A.S. Aquaporin-4 gene deletion in mice increases focal edema associated with staphylococcal brain abscess. J Neurochem 2005, 95:254-262.
13. Boldin C., Raith J., Fankhauser F., Haunschmid C., Schwantzer G., Schweighofer F. Predicting neurologic recovery in cervical spinal cord injury with postoperative MR imaging. Spine 2006, 31:554-559.
14. Bracken M.B., Shepard M.J., Collins W.F., Holford T.R., Young W., Baskin D.S., Eisenberg H.M., Flamm E., Leo-Summers L., Maroon J., et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990, 322:1405-1411.
15. Bracken M.B., Shepard M.J., Holford T.R., Leo-Summers L., Aldrich E.F., Fazl M., Fehlings M., Herr D.L., Hitchon P.W., Marshall L.F., Nockels R.P., Pascale V., Perot P.L., Piepmeier J., Sonntag V.K., Wagner F., Wilberger J.E., Winn H.R., Young W. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 1997, 277:1597-1604.
16. Crane J.M., Van Hoek A.N., Skach W.R., Verkman A.S. Aquaporin-4 dynamics in orthogonal arrays in live cells visualized by quantum dot single particle tracking. Mol Biol Cell 2008, 19:3369-3378.
17. Crane J.M., Verkman A.S. Determinants of aquaporin-4 assembly in orthogonal arrays revealed by live-cell single-molecule fluorescence imaging. J Cell Sci 2009, 122:813-821.
18. Czosnyka M., Hutchinson P.J., Balestreri M., Hiler M., Smielewski P., Pickard J.D. Monitoring and interpretation of intracranial pressure after head injury. Acta Neurochir Suppl 2006, 96:114-118.
19. Czosnyka M., Smielewski P., Timofeev I., Lavinio A., Guazzo E., Hutchinson P., Pickard J.D. Intracranial pressure: more than a number. Neurosurg Focus 2007, 22:E10.
20. Denker B.M., Smith B.L., Kuhajda F.P., Agre P. Identification, purification, and partial characterization of a novel Mr 28,000 integral membrane protein from erythrocytes and renal tubules. J Biol Chem 1988, 263:15634-15642.
21. Dolman D., Drndarski S., Abbott N.J., Rattray M. Induction of aquaporin 1 but not aquaporin 4 messenger RNA in rat primary brain microvessel endothelial cells in culture. J Neurochem 2005, 93:825-833.
22. Edwards P., Arango M., Balica L., Cottingham R., El-Sayed H., Farrell B., Fernandes J., Gogichaisvili T., Golden N., Hartzenberg B., Husain M., Ulloa M.I., Jerbi Z., Khamis H., Komolafe E., Laloe V., Lomas G., Ludwig S., Mazairac G., Munoz Sanchez Mde L., Nasi L., Olldashi F., Plunkett P., Roberts I., Sandercock P., Shakur H., Soler C., Stocker R., Svoboda P., Trenkler S., Venkataramana N.K., Wasserberg J., Yates D., Yutthakasemsunt S. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet 2005, 365:1957-1959.
23. Fehlings M.G., Perrin R.G. The timing of surgical intervention in the treatment of spinal cord injury: a systematic review of recent clinical evidence. Spine 2006, 31:S28-S35. discussion:S36.
24. Flanders A.E., Spettell C.M., Friedman D.P., Marino R.J., Herbison G.J. The relationship between the functional abilities of patients with cervical spinal cord injury and the severity of damage revealed by MR imaging. AJNR Am J Neuroradiol 1999, 20:926-934.
25. Fujii H., Yone K., Sakou T. Magnetic resonance imaging study of experimental acute spinal cord injury. Spine 1993, 18:2030-2034.
26. Furman C.S., Gorelick-Feldman D.A., Davidson K.G., Yasumura T., Neely J.D., Agre P., Rash J.E. Aquaporin-4 square array assembly: opposing actions of M1 and M23 isoforms. Proc Natl Acad Sci U S A 2003, 100:13609-13614.
27. Hara-Chikuma M., Sohara E., Rai T., Ikawa M., Okabe M., Sasaki S., Uchida S., Verkman A.S. Progressive adipocyte hypertrophy in aquaporin-7-deficient mice: adipocyte glycerol permeability as a novel regulator of fat accumulation. J Biol Chem 2005, 280:15493-15496.
28. Hinson S.R., Pittock S.J., Lucchinetti C.F., Roemer S.F., Fryer J.P., Kryzer T.J., Lennon V.A. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 2007, 69:2221-2231.
29. Huber V.J., Tsujita M., Kwee I.L., Nakada T. Inhibition of aquaporin 4 by antiepileptic drugs. Bioorg Med Chem 2009, 17:418-424.
30. Huber V.J., Tsujita M., Nakada T. Identification of aquaporin 4 inhibitors using in vitro and in silico methods. Bioorg Med Chem 2009, 17:411-417.
31. Huber V.J., Tsujita M., Yamazaki M., Sakimura K., Nakada T. Identification of arylsulfonamides as aquaporin 4 inhibitors. Bioorg Med Chem Lett 2007, 17:1270-1273.
32. Hutchinson P., Timofeev I., Kirkpatrick P. Surgery for brain edema. Neurosurg Focus 2007, 22:E14.
33. Jarius S., Aboul-Enein F., Waters P., Kuenz B., Hauser A., Berger T., Lang W., Reindl M., Vincent A., Kristoferitsch W. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 2008, 131:3072-3080.
34. Jarius S., Paul F., Franciotta D., Waters P., Zipp F., Hohlfeld R., Vincent A., Wildemann B. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 2008, 4:202-214.
35. Klatzo I. Evolution of brain edema concepts. Acta Neurochir Suppl (Wien) 1994, 60:3-6.
36. Kleffner I., Bungeroth M., Schiffbauer H., Schabitz W.R., Ringelstein E.B., Kuhlenbaumer G. The role of aquaporin-4 polymorphisms in the development of brain edema after middle cerebral artery occlusion. Stroke 2008, 39:1333-1335.
37. Lang E.W., Chesnut R.M. Intracranial pressure and cerebral perfusion pressure in severe head injury. New Horiz 1995, 3:400-409.
38. Lennon V.A., Kryzer T.J., Pittock S.J., Verkman A.S., Hinson S.R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005, 202:473-477.
39. Lennon V.A., Wingerchuk D.M., Kryzer T.J., Pittock S.J., Lucchinetti C.F., Fujihara K., Nakashima I., Weinshenker B.G. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004, 364:2106-2112.
40. Liang D., Bhatta S., Gerzanich V., Simard J.M. Cytotoxic edema: mechanisms of pathological cell swelling. Neurosurg Focus 2007, 22:E2.
41. Ma T., Yang B., Gillespie A., Carlson E.J., Epstein C.J., Verkman A.S. Generation and phenotype of a transgenic knockout mouse lacking the mercurial-insensitive water channel aquaporin-4. J Clin Invest 1997, 100:957-962.
42. Manley G.T., Fujimura M., Ma T., Noshita N., Filiz F., Bollen A.W., Chan P., Verkman A.S. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 2000, 6:159-163.
43. Marmarou A. A review of progress in understanding the pathophysiology and treatment of brain edema. Neurosurg Focus 2007, 22:E1.
44. Marmarou A., Hochwald G., Nakamura T., Tanaka K., Weaver J., Dunbar J. Brain edema resolution by CSF pathways and brain vasculature in cats. Am J Physiol 1994, 267:H514-H520.
45. McClelland S., Long D.M. Genesis of the use of corticosteroids in the treatment and prevention of brain edema. Neurosurgery 2008, 62:965-967. discussion:967-968.
46. Miller S.M. Methylprednisolone in acute spinal cord injury: a tarnished standard. J Neurosurg Anesthesiol 2008, 20:140-142.
47. Misu T., Fujihara K., Kakita A., Konno H., Nakamura M., Watanabe S., Takahashi T., Nakashima I., Takahashi H., Itoyama Y. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007, 130:1224-1234.
48. Miyanji F., Furlan J.C., Aarabi B., Arnold P.M., Fehlings M.G. Acute cervical traumatic spinal cord injury: MR imaging findings correlated with neurologic outcome-prospective study with 100 consecutive patients. Radiology 2007, 243:820-827.
49. Nesic O., Lee J., Ye Z., Unabia G.C., Rafati D., Hulsebosch C.E., Perez-Polo J.R. Acute and chronic changes in aquaporin 4 expression after spinal cord injury. Neuroscience 2006, 143:779-792.
50. Nielsen S., Smith B.L., Christensen E.I., Agre P. Distribution of the aquaporin CHIP in secretory and resorptive epithelia and capillary endothelia. Proc Natl Acad Sci U S A 1993, 90:7275-7279.
51. Nout Y.S., Mihai G., Tovar C.A., Schmalbrock P., Bresnahan J.C., Beattie M. Hypertonic saline attenuates cord swelling and edema in experimental spinal cord injury: a study utilizing magnetic resonance imaging. Crit Care Med 2009, 37:2160-2166.
52. Oshio K., Binder D.K., Yang B., Schecter S., Verkman A.S., Manley G.T. Expression of aquaporin water channels in mouse spinal cord. Neuroscience 2004, 127:685-693.
53. Oshio K., Watanabe H., Song Y., Verkman A.S., Manley G.T. Reduced cerebrospinal fluid production and intracranial pressure in mice lacking choroid plexus water channel aquaporin-1. FASEB J 2005, 19:76-78.
54. Oshio K., Watanabe H., Yan D., Verkman A.S., Manley G.T. Impaired pain sensation in mice lacking aquaporin-1 water channels. Biochem Biophys Res Commun 2006, 341:1022-1028.
55. Papadopoulos M.C., Binder D.K., Verkman A.S. Enhanced macromolecular diffusion in brain extracellular space in mouse models of vasogenic edema measured by cortical surface photobleaching. FASEB J 2005, 19:425-427.
56. Papadopoulos M.C., Manley G.T., Krishna S., Verkman A.S. Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J 2004, 18:1291-1293.
57. Papadopoulos M.C., Saadoun S., Verkman A.S. Aquaporins and cell migration. Pflugers Arch 2008, 456:693-700.
58. Papadopoulos M.C., Verkman A.S. Aquaporin-4 gene disruption in mice reduces brain swelling and mortality in pneumococcal meningitis. J Biol Chem 2005, 280:13906-13912.
59. Papadopoulos M.C., Verkman A.S. Potential utility of aquaporin modulators for therapy of brain disorders. Prog Brain Res 2008, 170:589-601.
60. Rash J.E., Yasumura T. Direct immunogold labeling of connexins and aquaporin-4 in freeze-fracture replicas of liver, brain, and spinal cord: factors limiting quantitative analysis. Cell Tissue Res 1999, 296:307-321.
61. Reulen H.J., Graham R., Spatz M., Klatzo I. Role of pressure gradients and bulk flow in dynamics of vasogenic brain edema. J Neurosurg 1977, 46:24-35.
62. Roemer S.F., Parisi J.E., Lennon V.A., Benarroch E.E., Lassmann H., Bruck W., Mandler R.N., Weinshenker B.G., Pittock S.J., Wingerchuk D.M., Lucchinetti C.F. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007, 130:1194-1205.
63. Rowland J.W., Hawryluk G.W., Kwon B., Fehlings M.G. Current status of acute spinal cord pathophysiology and emerging therapies: promise on the horizon. Neurosurg Focus 2008, 25:E2.
64. Saadoun S., Bell B.A., Verkman A.S., Papadopoulos M.C. Greatly improved neurological outcome after spinal cord compression injury in AQP4-deficient mice. Brain 2008, 131:1087-1098.
65. Saadoun S., Papadopoulos M.C., Davies D.C., Bell B.A., Krishna S. Increased aquaporin 1 water channel expression in human brain tumours. Br J Cancer 2002, 87:621-623.
66. Saadoun S., Papadopoulos M.C., Davies D.C., Krishna S., Bell B.A. Aquaporin-4 expression is increased in oedematous human brain tumours. J Neurol Neurosurg Psychiatry 2002, 72:262-265.
67. Saadoun S., Papadopoulos M.C., Hara-Chikuma M., Verkman A.S. Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption. Nature 2005, 434:786-792.
68. Saadoun S., Papadopoulos M.C., Watanabe H., Yan D., Manley G.T., Verkman A.S. Involvement of aquaporin-4 in astroglial cell migration and glial scar formation. J Cell Sci 2005, 118:5691-5698.
69. Shapiro K., Marmarou A., Shulman K. Characterization of clinical CSF dynamics and neural axis compliance using the pressure-volume index: I. The normal pressure-volume index. Ann Neurol 1980, 7:508-514.
70. Sharma H.S., Badgaiyan R.D., Alm P., Mohanty S., Wiklund L. Neuroprotective effects of nitric oxide synthase inhibitors in spinal cord injury-induced pathophysiology and motor functions: an experimental study in the rat. Ann N Y Acad Sci 2005, 1053:422-434.
71. Silberstein C., Bouley R., Huang Y., Fang P., Pastor-Soler N., Brown D., Van Hoek A.N. Membrane organization and function of M1 and M23 isoforms of aquaporin-4 in epithelial cells. Am J Physiol Renal Physiol 2004, 287:F501-F511.
72. Sorani M.D., Zador Z., Hurowitz E., Yan D., Giacomini K.M., Manley G.T. Novel variants in human aquaporin-4 reduce cellular water permeability. Hum Mol Genet 2008, 17:2379-2389.
73. Tait M.J., Saadoun S., Bell B.A., Papadopoulos M.C. Water movements in the brain: role of aquaporins. Trends Neurosci 2008, 31:37-43.
74. Tanimura Y., Hiroaki Y., Fujiyoshi Y. Acetazolamide reversibly inhibits water conduction by aquaporin-4. J Struct Biol 2009, 166:16-21.
75. Timofeev I., Czosnyka M., Nortje J., Smielewski P., Kirkpatrick P., Gupta A., Hutchinson P. Effect of decompressive craniectomy on intracranial pressure and cerebrospinal compensation following traumatic brain injury. J Neurosurg 2008, 108:66-73.
76. Uhl E., Kreth F.W., Elias B., Goldammer A., Hempelmann R.G., Liefner M., Nowak G., Oertel M., Schmieder K., Schneider G.H. Outcome and prognostic factors of hemicraniectomy for space occupying cerebral infarction. J Neurol Neurosurg Psychiatry 2004, 75:270-274.
77. Verkman A.S. Dissecting the roles of aquaporins in renal pathophysiology using transgenic mice. Semin Nephrol 2008, 28:217-226.
78. Verkman A.S. Knock-out models reveal new aquaporin functions. Handb Exp Pharmacol 2009, 190:359-381.
79. Verkman A.S., Hara-Chikuma M., Papadopoulos M.C. Aquaporins-new players in cancer biology. J Mol Med 2008, 86:523-529.
80. Verkman A.S., Mitra A.K. Structure and function of aquaporin water channels. Am J Physiol Renal Physiol 2000, 278:F13-F28.
81. Wagner F.C., Stewart W.B. Effect of trauma dose on spinal cord edema. J Neurosurg 1981, 54:802-806.
82. Wang Y.F., Gu Y.T., Xu W.B., Lv G. Temporary loss of perivascular aquaporin-4 in white matter after the spinal cord ischemic injury of rats. Neuroreport 2009, 20:145-149.
83. Warth A., Kroger S., Wolburg H. Redistribution of aquaporin-4 in human glioblastoma correlates with loss of agrin immunoreactivity from brain capillary basal laminae. Acta Neuropathol 2004, 107:311-318.
84. Wingerchuk D.M., Lennon V.A., Lucchinetti C.F., Pittock S.J., Weinshenker B.G. The spectrum of neuromyelitis optica. Lancet Neurol 2007, 6:805-815.
85. Wingerchuk D.M., Weinshenker B.G. Neuromyelitis optica. Curr Treat Options Neurol 2008, 10:55-66.
86. Xu W.B., Gu Y.T., Wang Y.F., Lu X.H., Jia L.S., Lv G. Bradykinin preconditioning modulates aquaporin-4 expression after spinal cord ischemic injury in rats. Brain Res 2008, 1246:11-18.
87. Yang B., Zador Z., Verkman A.S. Glial cell aquaporin-4 overexpression in transgenic mice accelerates cytotoxic brain swelling. J Biol Chem 2008, 283:15280-15286.
88. Yang B., Zhang H., Verkman A.S. Lack of aquaporin-4 water transport inhibition by antiepileptics and arylsulfonamides. Bioorg Med Chem 2008, 16:7489-7493.
89. Zeynalov E., Chen C.H., Froehner S.C., Adams M.E., Ottersen O.P., Amiry-Moghaddam M., Bhardwaj A. The perivascular pool of aquaporin-4 mediates the effect of osmotherapy in postischemic cerebral edema. Crit Care Med 2008, 36:2634-2640.